Houston-area company inks massive $1B deal for weight-loss drug

Calls for weight loss drugs to be added to the PBS

The cost of prescriptions for weight loss drugs is being brought into question with doctors pushing for the...

Houston-area company inks massive $1B deal for weight-loss drug

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker of Ozempic, Novo Nordisk.

Over the past three years, the number of Norwegians who use at least one drug to lose weight has increased significantly. Its use has also increased among children between the ages of 12 and 17.

Over the past three years, the number of Norwegians who use at least one drug to lose weight has increased significantly. Its use has also increased among children between the ages of 12 and 17.

In recent years, there has been a marked increase in the use of drugs used to treat overweight and obesity. The use of newer drugs is particularly increasing, new figures from the Norwegian Institute of Public Health show.